Literature DB >> 9610528

Remodeling of in-stent neointima, which became thinner and transparent over 3 years: serial angiographic and angioscopic follow-up.

M Asakura1, Y Ueda, S Nanto, A Hirayama, T Adachi, M Kitakaze, M Hori, K Kodama.   

Abstract

BACKGROUND: Recently, it has been reported that the luminal diameter shows phasic changes after stenting: the progression of luminal narrowing followed by its regression. To elucidate the mechanisms involved in the phasic changes in luminal diameter after stenting, we examined the changes in neointimal thickness and the appearance of neointima by a series of angiographic and angioscopic observations for 3 years after stent implantation. METHODS AND
RESULTS: In 12 patients who received a Wiktor coronary stent, serial angiographic and angioscopic examinations were performed immediately, 2 to 4 weeks, 3 months, 6 months, and 3 years after the stenting without repetition of angioplasty. Neointimal thickness was determined by angiography as the difference between stent and luminal diameters. The angioscopic appearance of neointima over the stent was classified as transparent or nontransparent according to the visibility of the majority of the stent. Neointimal thickness increased significantly at 3 months (0.75+/-0.32 mm) without further changes at 6 months (0.74+/-0.32 mm). Thereafter, however, it decreased significantly over 3 years (0.51+/-0.26 mm). The angioscopic appearance was classified as transparent in 8 patients (100) immediately after stenting, 6 patients (100%) at 2 to 4 weeks, 2 patients (17%) at 3 months, 2 patients (20%) at 6 months, and 7 patients (58%) at 3 years.
CONCLUSIONS: The neointima became thick and nontransparent until 6 months and then became thin and transparent by 3 years. We conclude that neointimal remodeling exists after stenting and plays a major role in the alteration of coronary luminal diameter after stenting.

Entities:  

Mesh:

Year:  1998        PMID: 9610528     DOI: 10.1161/01.cir.97.20.2003

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  22 in total

1.  Neointimal tissue characteristics following sirolimus-eluting stent implantation: OCT quantitative tissue property analysis.

Authors:  Jingbo Hou; Haibo Jia; Haixia Liu; Zhigang Han; Shuang Yang; Chenyang Xu; Joseph Schmitt; Shaosong Zhang; Bo Yu; Ik-Kyung Jang
Journal:  Int J Cardiovasc Imaging       Date:  2012-03-16       Impact factor: 2.357

2.  Accumulation and loss of extracellular matrix during shear stress-mediated intimal growth and regression in baboon vascular grafts.

Authors:  Richard D Kenagy; Jens W Fischer; Stephanie Lara; John D Sandy; Alexander W Clowes; Thomas N Wight
Journal:  J Histochem Cytochem       Date:  2005-01       Impact factor: 2.479

3.  A link between smooth muscle cell death and extracellular matrix degradation during vascular atrophy.

Authors:  Richard D Kenagy; Seung-Kee Min; Eileen Mulvihill; Alexander W Clowes
Journal:  J Vasc Surg       Date:  2011-04-14       Impact factor: 4.268

4.  Cell death-associated ADAMTS4 and versican degradation in vascular tissue.

Authors:  Richard D Kenagy; Seung-Kee Min; Alexander W Clowes; John D Sandy
Journal:  J Histochem Cytochem       Date:  2009-06-08       Impact factor: 2.479

5.  Difference in neointimal coverage at chronic stage between bare metal stent and sirolimus-eluting stent evaluated at stent-strut level by optical coherence tomography.

Authors:  Shinichiro Ikuta; Kazuhiro Kobuke; Yoshitaka Iwanaga; Yoshifumi Nakauchi; Kenji Yamaji; Shunichi Miyazaki
Journal:  Heart Vessels       Date:  2013-06-21       Impact factor: 2.037

6.  Bone morphogenetic protein 4: potential regulator of shear stress-induced graft neointimal atrophy.

Authors:  Patrick C H Hsieh; Richard D Kenagy; Eileen R Mulvihill; Joseph P Jeanette; Xi Wang; Cindy M C Chang; Zizhen Yao; Walter L Ruzzo; Suzanne Justice; Kelly L Hudkins; Charles E Alpers; Scott Berceli; Alexander W Clowes
Journal:  J Vasc Surg       Date:  2006-01       Impact factor: 4.268

7.  Long term angiographic and clinical follow up in patients with stent implantation for symptomatic myocardial bridging.

Authors:  P K Haager; E R Schwarz; J vom Dahl; H G Klues; T Reffelmann; P Hanrath
Journal:  Heart       Date:  2000-10       Impact factor: 5.994

8.  Pravastatin and endothelium dependent vasomotion after coronary angioplasty: the PREFACE trial.

Authors:  H J Mulder; M J Schalij; B Kauer; R F Visser; P R van Dijkman; J W Jukema; A H Zwinderman; A V Bruschke
Journal:  Heart       Date:  2001-11       Impact factor: 5.994

9.  Acute myocardial infarction caused by thrombotic occlusion at a stent site two years after conventional stent implantation.

Authors:  T Hayashi; A Kimura; K Ishikawa
Journal:  Heart       Date:  2004-05       Impact factor: 5.994

Review 10.  Induction of vascular atrophy as a novel approach to treating restenosis. A review.

Authors:  Seung-Kee Min; Richard D Kenagy; Alexander W Clowes
Journal:  J Vasc Surg       Date:  2007-10-22       Impact factor: 4.268

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.